The AHSN Network is helping to transform Attention Deficit Hyperactivity Disorder (ADHD) services across England with the rollout of technology that can provide an objective assessment and help families to receive a diagnosis more quickly.
New figures released during ADHD Awareness Month (October) show that, since the start of the first ‘demonstrator’ site in the East Midlands in 2017, 52,000 children across England have had an objective assessment for ADHD using the QbTest technology.
The QbTest has a strong evidence base that shows direct benefits for the patient, their family as well as the wider healthcare system.
Following the real-world demonstrator project commissioned by East Midlands AHSN in 2017, the team is leading the national Focus ADHD programme across all 15 AHSNs to roll the test out across the country.
Despite Covid restrictions, nearly 10,000 children benefited from undertaking a QbTest in 2020/21. A further 9,500 tests have been completed by the end of September 2021 at 51 trusts across 100 sites.
Visit the East Midlands Academic Health Science Network website to find out more about their work on Focus ADHD.
Find out more about the AHSN Network Focus ADHD programme.
Pete Waddingham, the Health Innovation Network's Net Zero Lead, discusses how we're supporting a Net Zero NHS through innovation, and its potential to reduce demand. We all know climate change contributes to poor health, with air pollution linked to a number of health conditions including cardiovascular disease, respiratory disease and cancer. We also know it’s [...]
Karina Malhotra (pictured on the right) is the Founder and Managing Director of Acumentice - a healthcare improvement consultancy. Karina’s background is in the NHS, with operational leadership roles in NHS Trusts across London. Her product, Evolve Learning, provides targeted learning and development for staff in the NHS. It’s delivered on an e-learning platform, in [...]
At the Health Innovation Network we have always had a dual focus on improving both the health and wealth of the nation and have demonstrated the huge contribution that the health and life sciences industry can make to economic growth. Since 2018, our support to innovators has leveraged £2.6 billion for the UK economy. We're [...]
